Protocol Ledger

NCT07303777 · Phase II · RECRUITING

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

Interventional Phase II clinical trial protocol NCT07303777 sponsored by Atom Therapeutics Co in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-23 Enrollment: 200 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07303777
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)200 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07303777
Protocol FieldVerified Registry Value
NCT IdentifierNCT07303777
Consolidated Lead SponsorAtom Therapeutics Co
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment200 participants (ESTIMATED)
Registered Start Date2026-04-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI